BioLineRx Ltd. (BLRX)

BioLineRx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	9.62	4.26	10.59	12.99	16.83	5.3
Short-Term Investments	30.44	38.74	40.5	44.15	5.76	22.19
Cash & Short-Term Investments	40.06	42.99	51.08	57.14	22.59	27.49
Cash Growth	22.08%	-15.83%	-10.59%	152.96%	-17.83%	-8.83%
Accounts Receivable	3.18	0.36	-	-	-	-
Other Receivables	0.66	0.83	0.72	0.14	0.14	0.61
Receivables	3.84	1.19	0.72	0.14	0.14	0.61
Inventory	3.63	1.95	-	-	-	-
Prepaid Expenses	1.58	1.05	0.2	0.13	0.15	0.11
Total Current Assets	49.11	47.18	52	57.4	22.88	28.21
Property, Plant & Equipment	1.8	1.89	2.5	2.28	2.7	3.47
Other Intangible Assets	13.69	14.85	21.89	21.7	21.71	21.89
Total Assets	64.6	63.93	76.38	81.39	47.29	53.57
Accounts Payable	6.27	10.87	6.97	5.57	5.92	7.79
Accrued Expenses	-	3.27	1.66	1.23	1.44	1.27
Current Portion of Long-Term Debt	10.66	3.15	1.54	2.76	3.09	2.69
Current Portion of Leases	0.5	0.53	0.43	0.17	0.19	0.2
Current Unearned Revenue	5.48	12.96	-	-	-	-
Other Current Liabilities	7.62	0.09	0.08	0	0	0.01
Total Current Liabilities	30.52	30.85	10.68	9.72	10.64	11.97
Long-Term Debt	18.79	6.63	8.63	-	2.74	5.8
Long-Term Leases	1.31	1.29	1.73	1.73	1.66	1.76
Other Long-Term Liabilities	-	11.93	4.51	1.86	10.22	0.66
Total Liabilities	50.62	50.7	25.54	13.3	25.26	20.19
Common Stock	34.41	31.36	27.1	21.07	9.87	4.69
Additional Paid-In Capital	352.43	355.48	338.98	339.35	279.24	265.94
Retained Earnings	-390.82	-390.61	-329.99	-305.04	-277.99	-247.97
Comprehensive Income & Other	17.96	16.99	14.76	12.72	10.91	10.72
Shareholders' Equity	13.98	13.22	50.84	68.09	22.03	33.38
Total Liabilities & Equity	64.6	63.93	76.38	81.39	47.29	53.57
Total Debt	31.26	11.59	12.32	4.65	7.68	10.46
Net Cash (Debt)	8.81	31.4	38.76	52.48	14.9	17.03
Net Cash Growth	-54.33%	-18.98%	-26.15%	252.17%	-12.51%	-20.47%
Net Cash Per Share	0.01	0.03	0.05	0.08	0.06	0.12
Filing Date Shares Outstanding	1,199	1,087	922.96	715.16	349.17	171.27
Total Common Shares Outstanding	1,199	1,087	922.96	715.16	349.17	171.27
Working Capital	18.59	16.33	41.32	47.69	12.24	16.24
Book Value Per Share	0.01	0.01	0.06	0.10	0.06	0.19
Tangible Book Value	0.29	-1.63	28.96	46.38	0.32	11.49
Tangible Book Value Per Share	0.00	-0.00	0.03	0.06	0.00	0.07
Machinery	-	2.93	2.81	2.66	2.56	2.56
Leasehold Improvements	-	2.04	2.04	2.03	2.03	2.03

Source: S&P Capital IQ. Standard template. Financial Sources.